Institute of Clinical Pharmacy and Pharmaceutical Sciences

Organization profile

Organisation profile

Many departments and institutes have been established since 1984, when National Cheng Kung University College of Medicine was founded. Due to the concern on over supply of pharmacy graduates, pharmacy school had never been considered during the planning of the College. When the affiliated Medical Center was started in 1988, pharmaceutical service required not only the product delivery but also a patient-oriented process of drug therapy. However, no clinically oriented pharmacy program was available nationwide at that time, and all the pharmacy graduates were trained under traditional programs.Therefore, the faculty of the Department of Pharmacology advocated the implementation of a master program on clinical pharmacy, which led to the establishment of the Institute of Clinical Pharmacy in 1991. Before its approval by the Ministry of Education, a consultative conference was held to integrate the comments and suggestions from academy of pharmaceutical sciences, health administrations, as well as pharmacy practitioners from hospitals. The first class of graduate students was admitted in August 1993, and Professor Ming-Liang Lai was appointed as Founding Chair. Since 1996, the programs in the Institute of Clinical Pharmacy were expanded to incorporate the pharmacokinetics division in addition to the hospital pharmacy division. A fellowship program, designed as one to two years of full-time training, was started in 2002. The Institute of Biopharmaceutical Sciences was proposed in association with the Institute of Clinical Medicine, the Department of Biochemistry and the Department of Pharmacology, and the first Doctor of Philosophy (Ph.D.) student will be admitted during 2003-04 academic year.

Fingerprint The fingerprint is based on mining the text of the scientific documents related to the associated persons. Based on that an index of weighted terms is created, which defines the key subjects of research unit

Taiwan Medicine & Life Sciences
Skin Medicine & Life Sciences
Metformin Medicine & Life Sciences
Cornea Medicine & Life Sciences
Vascular Stiffness Medicine & Life Sciences
Chronic Renal Insufficiency Medicine & Life Sciences
Hairless Mouse Medicine & Life Sciences
Population Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 1996 2018

Research Output 1991 2018

3 Citations

Cardiovascular and bleeding risks in acute myocardial infarction newly treated with ticagrelor vs. Clopidogrel in Taiwan

Lee, C. H., Cheng, C-L., Kao, Y-H., Chao, T-H., Chen, J. Y. & Li, Y-H., 2018 Jan 1, In : Circulation Journal. 82, 3, p. 747-756 10 p.

Research output: Contribution to journalArticle

Myocardial Infarction

Characterization of CRISPR-Cas systems in clinical Klebsiella pneumoniae isolates uncovers its potential association with antibiotic susceptibility

Li, H. Y., Kao, C. Y., Lin, W. H., Zheng, P. X., Yan, J. J., Wang, M-C., Teng, C. H., Tseng, C-C. & Wu, J. J., 2018 Jul 16, In : Frontiers in Microbiology. 9, JUL, 1595.

Research output: Contribution to journalArticle

CRISPR-Cas Systems
Klebsiella pneumoniae
Anti-Bacterial Agents
Microbial Drug Resistance

Clinical and microbiological characteristics of peritoneal dialysis-related peritonitis caused by Escherichia coli in southern Taiwan

Lin, W. H., Tseng, C-C., Wu, A. B., Chang, Y. T., Kuo, T. H., Chao, J. Y., Wang, M-C. & Wu, J. J., 2018 Sep 1, In : European Journal of Clinical Microbiology and Infectious Diseases. 37, 9, p. 1699-1707 9 p.

Research output: Contribution to journalArticle

Peritoneal Dialysis
Escherichia coli
Treatment Failure